AONC — American Oncology Network Share Price
Last trade - 00:00- $304.74m
- $408.28m
- $1.76bn
- 22
- 55
- 65
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 11.14 | ||
| Price to Tang. Book | 21.82 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.17 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.88% | ||
| Return on Equity | n/a | ||
| Operating Margin | -0.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 724.74 | 943.75 | 1,149.67 | 1,279.18 | 1,759.48 | n/a | n/a | 24.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
American Oncology Network, Inc. is an alliance of physicians and seasoned healthcare leaders. The Company has offered a progressive model of physician-led, community-based oncology management. Its business is focused on caring for adult and senior populations with medical oncology and related care needs, including members of Medicare Advantage (MA) plan run by private insurance companies on behalf of the Centers for Medicare and Medicaid Services (CMS) as well as traditional Fee-For-Service (FFS) Medicare, Medicaid, other government healthcare programs and commercial insurance populations. It provides patients with a variety of services, including in-house professional and technical pathology, providing complete pathology reports; in-house specialty pharmacy with patient education, financial assistance and 24/7 patient assistance, and care management support services including nutrition guidance. Its network represents more than 266 physicians across 102 locations in 20 states.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 17th, 2020
- Public Since
- March 10th, 2021
- No. of Shareholders
- 278
- No. of Employees
- 1,914
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 46,955,587
- Address
- 14543 Global Pkwy #110, FORT MYERS, 33913
- Web
- https://www.aoncology.com/
- Phone
- +1 3609491111
- Auditors
- PricewaterhouseCoopers LLP
Similar to AONC
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
Aesthetic Medical International Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 07:15 UTC, shares in American Oncology Network are trading at $6.49. This share price information is delayed by 15 minutes.
Shares in American Oncology Network last closed at $6.49 and the price had moved by +66.84% over the past 365 days. In terms of relative price strength the American Oncology Network share price has outperformed the S&P500 Index by +55.87% over the past year.
There is no consensus recommendation for this security.
Find out moreAmerican Oncology Network does not currently pay a dividend.
American Oncology Network does not currently pay a dividend.
American Oncology Network does not currently pay a dividend.
To buy shares in American Oncology Network you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $6.49, shares in American Oncology Network had a market capitalisation of $304.74m.
Here are the trading details for American Oncology Network:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: AONC
Based on an overall assessment of its quality, value and momentum American Oncology Network is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like American Oncology Network. Over the past six months, its share price has outperformed the S&P500 Index by +116.71%.
As of the last closing price of $6.49, shares in American Oncology Network were trading +64.11% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The American Oncology Network PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.49.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on American Oncology Network's directors